心脏移植影像学综述:侵入与非侵入模态在CAV和排斥监测中的应用
本文综述心脏移植后冠状动脉移植物血管病(CAV)和急性排斥反应的侵入性与非侵入性影像监测方法。冠状动脉造影是CAV常规监测基石但具侵入性且早期低估严重程度,血管内超声和光学相干断层扫描可检测造影未见的早期CAV病变。非侵入性影像包括心肌灌注、解剖结构和功能成像,均提供临床与预后信息并可能作为侵入性监测的守门人,尚无单一模态提供移植物功能、冠状动脉解剖和心肌灌注的完整信息,建议不同阶段联合应用以实现个体化监测和风险分层。
要点
- 冠状动脉造影是CAV常规监测基石,但侵入性且早期低估病变严重程度。
- 血管内超声和光学相干断层扫描可检测造影未见的早期CAV病变。
- 非侵入性影像提供临床与预后信息,可能作为侵入性监测的守门人。
核心结论
- 急性排斥和CAV仍是心脏移植后的重要临床问题,尚无单一影像模态能完整提供移植物功能、冠状动脉解剖和心肌灌注信息。
- 建议在心脏移植后不同阶段联合侵入性与非侵入性模态,以实现最佳个体化监测和风险分层。
研究设计与样本
- 本文为综述,聚焦侵入性与非侵入性影像模态在检测和监测心脏移植后CAV及排斥反应中的使用与可靠性。
主要发现
- 冠状动脉造影是CAV常规监测基石,但具侵入性且尤其早期低估CAV严重程度。
- 血管内超声和光学相干断层扫描为侵入性冠状动脉内成像方法,可检测造影未显现的早期CAV病变。
- 非侵入性影像可分为心肌灌注成像、解剖/结构成像和心肌功能成像,均提供临床与预后信息并可能对侵入性监测起守门人作用。
临床怎么用
- 心脏移植后CAV常规监测以冠状动脉造影为基石,但需认识其侵入性和早期低估局限。
- 对造影未见的早期CAV病变,可考虑血管内超声或光学相干断层扫描等侵入性冠状动脉内成像。
- 非侵入性影像可用于提供临床与预后信息,并可能作为侵入性监测的守门人。
- 心脏移植后不同阶段应联合侵入性与非侵入性模态进行个体化监测和风险分层。
局限性
- 尚无单一影像模态能完整提供移植物功能、冠状动脉解剖和心肌灌注信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Heart transplantation (HTx) remains the optimal treatment for selected patients with end-stage advanced heart failure. However, survival is limited early by acute rejection and long term by cardiac allograft vasculopathy (CAV). Even though the diagnosis of rejection is based on histology, cardiac imaging provides a pivotal role for early detection and severity assessment of these hazards. The present review focuses on the use and reliability of different invasive and non-invasive imaging modalities to detect and monitor CAV and rejection after HTx. Coronary angiography remains the corner stone in routine CAV surveillance. However, angiograms are invasive and underestimates the CAV severity especially in the early phase. Intravascular ultrasound and optical coherence tomography are invasive methods for intracoronary imaging that detects early CAV lesions not evident by angiograms. Non-invasive imaging can be divided into myocardial perfusion imaging, anatomical/structural imaging and myocardial functional imaging. The different non-invasive imaging modalities all provide clinical and prognostic information and may have a gatekeeper role for invasive monitoring. Acute rejection and CAV are still significant clinical problems after HTx. No imaging modality provides complete information on graft function, coronary anatomy and myocardial perfusion. However, a combination of invasive and non-invasive modalities at different stages following HTx should be considered for optimal personalized surveillance and risk stratification.
引用
- Clemmensen TS, Jensen NM, Eiskjær H, et al. Imaging of Cardiac Transplantation: An Overview. Semin Nucl Med. 2021. PMID: 33455723. doi:10.1053/j.semnuclmed.2020.12.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。